Metformin vs. Febuxostat for gout in obesity without diabetes
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study compares two medicines—metformin (usually for diabetes) and febuxostat (for gout)—in people who have both gout and obesity but not diabetes. The goal is to see which works better for controlling gout and related health markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with gout (a type of arthritis from uric acid crystals).
- Your blood uric acid level is less than 7 mg/dL.
- You are obese, with a body mass index (BMI) of 30 or higher.
- You do NOT have diabetes.
- You are not taking medications that cause high uric acid (like some blood pressure or chemotherapy drugs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if metformin, a common diabetes drug, can help people with gout. It aims to see if the drug is safe and effective for reducing gout symptoms.
This trial tests a new medicine called tigulixostat against febuxostat, a standard gout treatment, to see which works better at lowering uric acid levels. You may qualify if you have gout with high uric acid and have not had a gout flare in the last month.
This study tests whether the weight loss drug orlistat, combined with weight management, can help lower uric acid levels in people who have both gout and obesity. If you join, you will take orlistat and receive guidance on healthy eating and activity.
This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.
This Phase 3 study compares starting febuxostat immediately during a gout flare versus delaying the start. It aims to see which timing helps control gout better and safely.
This trial tests if febuxostat, a medicine used for gout, can help people recover from a brain bleed (intracranial hemorrhage) when surgery is not needed. It may reduce inflammation and improve outcomes.
Hear when a new Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.